Kurs
-0,15%
Kurs
-0,15%
Open
68,90
High
69,30
Low
66,30
Close
68,70
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
5,02 MNOK
Likviditet
5,02 MNOK
Rel. mcap
0,56%
Antal aktier
73 476
Likviditet under dagen för detta pressmeddelande
Kalender
| Tid* | ||
| 2026-02-25 | N/A | Bokslutskommuniké 2025 |
| 2025-11-26 | N/A | Kvartalsrapport 2025-Q3 |
| 2025-08-20 | N/A | Kvartalsrapport 2025-Q2 |
| 2025-05-22 | N/A | Årsstämma |
| 2025-05-14 | N/A | Kvartalsrapport 2025-Q1 |
| 2025-02-26 | N/A | Bokslutskommuniké 2024 |
| 2024-11-27 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-21 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-21 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
| 2024-05-16 | - | Årsstämma |
| 2024-05-14 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-28 | - | Bokslutskommuniké 2023 |
| 2023-11-15 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-23 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-16 | - | Kvartalsrapport 2023-Q1 |
| 2023-05-12 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
| 2023-05-11 | - | Årsstämma |
| 2023-02-28 | - | Bokslutskommuniké 2022 |
| 2022-11-23 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-24 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-16 | - | Kvartalsrapport 2022-Q1 |
| 2022-05-13 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
| 2022-05-12 | - | Årsstämma |
| 2022-03-31 | - | Bokslutskommuniké 2021 |
| 2021-12-22 | - | Extra Bolagsstämma 2021 |
| 2021-11-17 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-26 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-12 | - | Kvartalsrapport 2021-Q1 |
| 2021-05-06 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
| 2021-05-05 | - | Årsstämma |
| 2021-04-21 | - | Bokslutskommuniké 2020 |
| 2020-11-17 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-27 | - | Kvartalsrapport 2020-Q2 |
| 2020-07-07 | - | Split NYKD 1:5 |
| 2020-07-06 | - | Extra Bolagsstämma |
| 2020-05-12 | - | Kvartalsrapport 2020-Q1 |
| 2020-04-22 | - | Extra Bolagsstämma |
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2021-10-12 18:18:06
Elar Consulting AS has today sold 500,000 shares in Vaccibody AS to Elar Holding
AS at NOK 67.5 per share. Following the transaction, Elar Consulting AS holds no
shares and Elar Holding AS holds 500,000 shares in Vaccibody AS.
Elar Consulting AS is 50% owned by Lars Lund-Roland, member of the board of
Vaccibody AS. Elar Holding AS is 100% owned by Elar Consulting AS.
Please see further details in attached document.